Global Market: China tightens scrutiny of humanoid robot IPOs amid valuation concerns

Chinese regulators are slowing a rush of humanoid-robot companies seeking stock-market listings as they examine whether soaring valuations and revenue linked to state-backed projects accurately reflect underlying commercial demand, people familiar with the matter told Reuters.

The move follows a volatile debut by Unitree Robotics, a maker of humanoid and quadruped robots. Its shares surged more than fivefold on their Shanghai debut last month before falling 55% from their peak, highlighting concerns over investor enthusiasm and valuations in the sector.

Read more: Global Market Today: Asian stocks edge higher, oil extends losses

Informal guidance slows IPO plans

Regulators have used informal guidance to discourage some humanoid-robot listings, according to people familiar with the matter. One person said humanoid IPOs had effectively been frozen for now, while another said there was no formal ban but described the situation as a sector-specific slowdown.

The regulatory scrutiny underscores Beijing's effort to temper investor enthusiasm around one of China's most closely watched investment themes while continuing to support a technology that has been identified as a national priority.

The China Securities Regulatory Commission did not respond to Reuters' request for comment.

The Information earlier reported that the CSRC had recently provided informal guidance to some investment banks and investment firms, raising the bar for approval of humanoid-robot IPOs.

At least six Chinese humanoid robotics companies are preparing to go public, including Deep Robotics, X Square Robot and AGIBOT.

Read more: US Market: Fed rate path, oil prices and AI concerns to shape Wall Street this week

Revenue quality under the microscope

Regulators are paying particular attention to whether revenue generated through projects backed by local governments can be sustained, according to a person close to investors in the humanoid-robot sector.

Robot data-collection centres, where machines are trained, and joint ventures in which local governments may provide most of the initial investment have generated significant revenue for some companies, the person said.

Such projects can help companies generate orders, support private-market valuations and meet listing requirements. Regulators, however, are examining whether these revenues represent sustainable demand from independent commercial customers.

The person estimated that valuations at some robotics companies could decline sharply if revenue associated with data-collection centres were excluded.

Concerns over revenue quality have also raised questions about what customers are actually purchasing and whether reported sales can be maintained without government support.

Shares in Mech-Mind have fallen nearly 20% from their debut-day high on September 1.

From hype to commercial deployment

The tougher regulatory approach does not indicate that Beijing is abandoning humanoid robotics, executives and investors said. Instead, the focus is increasingly shifting toward actual deployment, order volumes and evidence that companies can turn technological demonstrations into commercially viable products.

Beijing has promoted embodied intelligence, referring to AI systems capable of perceiving and acting in the physical world, as a strategic emerging industry. That policy support has attracted substantial investment from private investors and local governments.

The investment boom has also encouraged traditional industrial-robot manufacturers to move into humanoid robotics, while startups have secured rapidly rising valuations. Some founders have attracted large numbers of prospective investors within weeks, with some private-market projects already seeing valuation reductions of 30% to 50%, according to venture investor Leo Wang of Qianchuang Capital.

Investors demand stronger evidence

The shift in regulatory scrutiny comes as China's capital markets experience a broader recovery. Mainland Chinese companies have raised $148.9 billion through share sales and convertible offerings so far in 2026, up 59% from the same period a year earlier, according to LSEG data. Technology companies accounted for 41% of the total.

Investors remain willing to finance robotics companies, but are becoming more selective about deployment, production volumes and valuations, a senior banker involved in Asian equity offerings said.

The increased scrutiny could therefore push China's humanoid-robot industry toward a more selective phase, with companies facing greater pressure to demonstrate recurring commercial demand rather than relying primarily on policy support, government-linked projects or expectations of future growth.

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)